Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cartesian Therapeutics | RNAC | Jan 16, 2025 | 18.93 | -0.11 |
Cartica Acquisition A | CITE | Jan 16, 2025 | 11.85 | 0.00 |
Carvana | CVNA | Jan 16, 2025 | 231.92 | +8.35 |
Carver Bancorp | CARV | Jan 16, 2025 | 1.82 | -1.39 |
Casella Waste Systems A | CWST | Jan 16, 2025 | 111.80 | -0.28 |
Caseys General Stores | CASY | Jan 16, 2025 | 390.98 | -0.08 |
CASI Pharmaceuticals | CASI | Jan 16, 2025 | 2.50 | -1.38 |
Cass Information Systems | CASS | Jan 16, 2025 | 40.26 | -0.52 |
Cassava Sciences | SAVA | Jan 16, 2025 | 2.69 | -0.92 |
Castellum | CTM | Jan 16, 2025 | 1.10 | +10.00 |
Castle Biosciences | CSTL | Jan 16, 2025 | 25.09 | +0.28 |
Castor Maritime | CTRM | Jan 16, 2025 | 2.81 | -1.75 |
Catalyst Bancorp | CLST | Jan 16, 2025 | 11.69 | 0.00 |
Catalyst Pharmaceuticals | CPRX | Jan 16, 2025 | 22.66 | -1.73 |
Caterpillar | CAT | Jan 16, 2025 | 380.55 | +1.51 |
Cathay General Bancorp | CATY | Jan 16, 2025 | 47.94 | -1.26 |
Catheter Precision | VTAK | Jan 16, 2025 | 0.47 | +4.26 |
Cato A | CATO | Jan 16, 2025 | 3.74 | +5.65 |
Cava Group | CAVA | Jan 16, 2025 | 117.51 | +1.64 |
Cavco Industries | CVCO | Jan 16, 2025 | 471.53 | +0.59 |
Cayson Acquisition Unit | CAPNU | Jan 16, 2025 | 10.12 | 0.00 |
CB Financial Services | CBFV | Jan 16, 2025 | 28.35 | +1.29 |
CBAK Energy Technology | CBAT | Jan 16, 2025 | 0.91 | -0.69 |
CbdMD | YCBD | Jan 16, 2025 | 0.56 | +10.72 |
cbdMD Pref A | YCBD-A | Jan 16, 2025 | 1.08 | -7.69 |
CBIZ | CBZ | Jan 16, 2025 | 84.74 | +1.00 |
CBL International | BANL | Jan 16, 2025 | 1.14 | -1.19 |
CBL& Associates Properties | CBL | Jan 16, 2025 | 28.60 | -1.07 |
CBOE Holdings | CBOE | Jan 16, 2025 | 193.92 | +0.78 |
Cbre Global Real Estate Income Fund | IGR | Jan 16, 2025 | 5.18 | +2.98 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.